A Behavioral Application for Improving Smoking Cessation Among Smokers

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFred Hutchinson Cancer Center

About this trial

This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.

Eligibility criteria

Qualifiers

Age 18 or older

Currently smoke, averaging at least 5 cigarettes/day for the last 30 days

Interested in quitting smoking in the next 30 days

Experience downloading and using one or more apps on their smartphone

Disqualifiers

Self-report of currently receiving behavioral treatment for depression (e.g., psychotherapy or counseling, web- or app-based interventions); current use of pharmacotherapy for depression or for other mental health conditions that are not otherwise excluded is allowable (e.g., benzodiazepines, anticonvulsants, opioid agonists, antipsychotics)

Severe depression (PHQ-9 ≥ 20)

Current suicidal ideation reported on the PHQ-9

History of a suicide attempt

Trial design

Treatments tested in this trial

  • Smartphone app-based Intervention (Actify! A app)
  • Smartphone app-based Intervention (Actify! B app)
  • Health Promotion and Education
  • Survey Administration

Treatment groups

1,812 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Fred Hutchinson Cancer Center

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator